Private Capital Group, LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 218 filers reported holding SAGE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.

Quarter-by-quarter ownership
Private Capital Group, LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$7,000
-12.5%
2300.0%0.01%
+150.0%
Q1 2022$8,000
+700.0%
230
+721.4%
0.00%
Q4 2021$1,000
-80.0%
28
-75.2%
0.00%
-100.0%
Q3 2021$5,000
-72.2%
113
-65.1%
0.00%
-75.0%
Q2 2021$18,000
-55.0%
324
-39.0%
0.00%
-60.0%
Q1 2021$40,000
+185.7%
531
+236.1%
0.01%
+233.3%
Q4 2020$14,000
+55.6%
158
+1.9%
0.00%
+50.0%
Q3 2020$9,000
+200.0%
155
+101.3%
0.00%
+100.0%
Q2 2020$3,0000.0%77
-32.5%
0.00%0.0%
Q1 2020$3,000
+200.0%
114
+470.0%
0.00%
Q4 2019$1,000
-93.8%
20
-82.6%
0.00%
-100.0%
Q3 2019$16,0001150.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Integral Health Asset Management, LLC 311,000$10,294,0002.68%
Palo Alto Investors LP 851,719$28,192,0002.18%
Boxer Capital, LLC 1,094,000$36,211,0001.86%
DAFNA Capital Management LLC 180,306$5,968,0001.56%
Deep Track Capital, LP 675,000$22,343,0001.43%
Bellevue Group AG 3,052,404$101,034,0001.17%
Ikarian Capital, LLC 249,907$8,272,0001.09%
Ikarian Capital, LLC 250,000$8,275,0001.09%
Artal Group S.A. 750,000$24,825,0001.04%
SECTOR GAMMA AS 118,476$3,922,0000.85%
View complete list of SAGE THERAPEUTICS INC shareholders